- Home
- Publications
- Publication Search
- Publication Details
Title
The role of P-glycoprotein in drug resistance in multiple myeloma
Authors
Keywords
-
Journal
LEUKEMIA & LYMPHOMA
Volume 56, Issue 1, Pages 26-33
Publisher
Informa UK Limited
Online
2014-03-29
DOI
10.3109/10428194.2014.907890
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of an ABCB1 (P-glycoprotein)-positive carfilzomib-resistant myeloma subpopulation by the pluripotent stem cell fluorescent dye CDy1
- (2013) Teresa S. Hawley et al. AMERICAN JOURNAL OF HEMATOLOGY
- The interaction of bortezomib with multidrug transporters: implications for therapeutic applications in advanced multiple myeloma and other neoplasias
- (2013) Robert O’Connor et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Pharmacokinetic evaluation of pomalidomide for the treatment of myeloma
- (2013) Francesca Gay et al. Expert Opinion on Drug Metabolism & Toxicology
- Novel Generation of Agents With Proven Clinical Activity in Multiple Myeloma
- (2013) María-Victoria Mateos et al. SEMINARS IN ONCOLOGY
- Pomalidomide: the new immunomodulatory agent for the treatment of multiple myeloma
- (2013) A A Chanan-Khan et al. Blood Cancer Journal
- Targeting MDR in breast and lung cancer: Discriminating its potential importance from the failure of drug resistance reversal studies
- (2012) Laleh Amiri-Kordestani et al. DRUG RESISTANCE UPDATES
- Can we change the disease biology of multiple myeloma?
- (2012) Ivan Borrello LEUKEMIA RESEARCH
- Overexpression of MDR1 and survivin, and decreased Bim expression mediate multidrug-resistance in multiple myeloma cells
- (2012) Masanobu Tsubaki et al. LEUKEMIA RESEARCH
- Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
- (2012) Philip L. McCarthy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drug interaction between lenalidomide and itraconazole
- (2011) Naoto Takahashi et al. AMERICAN JOURNAL OF HEMATOLOGY
- Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide
- (2011) Y. X. Zhu et al. BLOOD
- Genetic variations in multiple myeloma II: association with effect of treatment
- (2011) Annette Vangsted et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Phase I Trial of Lenalidomide and CCI-779 in Patients With Relapsed Multiple Myeloma: Evidence for Lenalidomide–CCI-779 Interaction via P-Glycoprotein
- (2011) Craig C. Hofmeister et al. JOURNAL OF CLINICAL ONCOLOGY
- Proteasome Regulator Marizomib (NPI-0052) Exhibits Prolonged Inhibition, Attenuated Efflux, and Greater Cytotoxicity than Its Reversible Analogs
- (2011) A. Obaidat et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Polymorphisms in the multiple drug resistance protein 1 and in P-glycoprotein 1 are associated with time to event outcomes in patients with advanced multiple myeloma treated with bortezomib and pegylated liposomal doxorubicin
- (2010) Gabriele Buda et al. ANNALS OF HEMATOLOGY
- Increased ABCB1 Expression in TP-110-Resistant RPMI-8226 Cells
- (2010) Masatomi IIJIMA et al. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
- The antihelmintic flubendazole inhibits microtubule function through a mechanism distinct from Vinca alkaloids and displays preclinical activity in leukemia and myeloma
- (2010) P. A. Spagnuolo et al. BLOOD
- Doxorubicin induces drug efflux pumps inCandida albicans
- (2010) Grzegorz Kofla et al. MEDICAL MYCOLOGY
- Influx and efflux transport as determinants of melphalan cytotoxicity: Resistance to melphalan in MDR1 overexpressing tumor cell lines
- (2009) Annett Kühne et al. BIOCHEMICAL PHARMACOLOGY
- Thalidomide alters nuclear architecture without ABCB1 gene modulation in drug-resistant myeloma cells
- (2009) Trussardi-Regnier INTERNATIONAL JOURNAL OF ONCOLOGY
- Comparative effects of drugs on P-glycoprotein expression and activity using rat and human trophoblast models
- (2009) D. Beghin et al. TOXICOLOGY IN VITRO
- Polymorphisms and haplotypes in the multidrug resistance 1 gene (MDR1/ABCB1) and risk of multiple myeloma
- (2008) Krzysztof Jamroziak et al. LEUKEMIA RESEARCH
- Psorospermin structural requirements for P-glycoprotein resistance reversal
- (2008) S. S. Carey et al. MOLECULAR CANCER THERAPEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started